Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAS-108 in Advanced Breast Cancer
NCT00166543Phase 2Completed
- Sponsor
- SRI International
- Start
- May 2004
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TAS-108 in breast cancer, sponsored by SRI International. Started May 2004; status: completed.
02
Drugs
TAS-108
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00166543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00166543.